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Receptor of advanced glycation end products (RAGE) was identified as one of the receptors for amyloid beta peptide (Ah). There is
evidence for controversial functions of RAGE such as a mediator of cell death or differentiation. In this report, we demonstrate that RAGE
mediates Ah toxicity. Transient transfection of RAGE already induced cell death. For further analysis, stable clones of hemagglutinin (HA)-
tagged RAGE were selected. Analysis of cellular localization of HA-tagged RAGE protein revealed, in addition to the expected cell surface
expression, a novel intracellular localization. Stable RAGE-expressing cells were hypersensitive to nanomolar amounts of Ah. Only cells
expressing RAGE at the cell surface showed hypersensitivity to Ah.
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The human receptor of advanced glycation end prod-
ucts (RAGE; AGER) is a 404 aa protein. Transmembrane
domain is assigned to a 21 aa region, resulting in a large
extracellular domain (320 aa) and a small intracellular
domain of 41 aa. RAGE belongs to a family of cell
surface molecules with immunoglobulin folds. Sequence
homologies exist to MUC18, a glycoprotein which also
belongs to the immunoglobulin superfamily and to neural
cell adhesion molecule (NCAM). Furthermore, the intra-
cellular domain of RAGE is similar to the B cell
activation marker CD20 [1]. RAGE is expressed in
endothelial cells, in mononuclear phagocytes (monocytes,
macrophages, mesangial cells), in neurons, and muscle
cells. On the other hand, the expression of RAGE on
neurons was refuted by Ref. [2]. During development,
RAGE is expressed at a high level in the nervous system
[3]. Induced expression is frequently associated with
pathological stages such as diabetical endothelial damage
and Alzheimer disease [4]. Recently, it was shown that
blocking of RAGE could restore wound healing in dia-0167-4889/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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infiltration, which provides the means to interfere with the
development of experimental autoimmune encephalomy-
elitis [6]. The Stern group [1] discovered RAGE as a
receptor for advanced glycation end products (AGEs).
AGEs can be built by non-enzymatic glycosylation of
proteins during aging or diabetes mellitus. Proteins with
slow turnover in tissues with low mitotic activity such as
in the central nervous system are frequently afflicted by
such glycosylation processes. There are additional physi-
ological ligands which bind to RAGE. Amphoterin, a 30
kDa developmental regulated protein is another RAGE
ligand [3]. Interestingly, amphoterin stimulates the out-
growth of neurites [3]. Furthermore, the RAGE ampho-
terin binding can lead to uncontrolled growth of brain
tumors and to the induction of metastasis, which might be
blocked by interference with the amphoterin/ RAGE
signaling [7].
One of the hallmarks of Alzheimer disease is the forma-
tion of deposits (plaques) within the brain of patients [8].
Later on, one of the major components of these plaques
could be identified as the amyloid beta peptide (Ah) derived
from amyloid precursor protein [9]. Ah was identified as a
neurotoxic and neurotrophic peptide dependent on the
concentration [10].
In order to establish a human model for Ah mediated
cell death, we transfected RAGE in cell lines. Here we
Fig. 1. In vitro translation of RAGE and RAGE HA cDNAs. Expression
vectors for RAGE cDNAwith or without hemagglutinin tag were submitted
to a coupled in vitro transcription and translation reaction. Reaction
products were separated on a SDS gel and visualized after blotting using
incorporated biotin labels, revealing the expected molecular weights
(RAGE, 50 kDa; RAGE HA, 53 kDa) of both products.
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high degree in intracellular compartments. Comparing the
induction of cell death by Ah in stable RAGE trans-
fectants, we found that cell surface expression is important
for induction of cell death. Cell surface expression of
RAGE results in a hypersensitivity against Ah even in
nanomolar doses, which were previously reported to be
neuroprotective [11].Fig. 2. Transient transfection of RAGE reveals induction of cell death. (A)
COS-1 cells were transfected with RAGE and lacZ expression vectors (left
panel) or with pUT SV1 and lacZ (right panel). Forty-eight hours after
transfection cells were fixed and stained with X-Gal. Transfected dead cells
were identified as small round pyknotic cells (arrow in left panel) in
comparison to living cells, depicting a flat morphology (arrow in right
panel). (B) Quantification of cell death in blue cells reveals a significant
amount of cell death in RAGE and RAGE HA tansfectants. Cell death of
blue cells was determined 48 h after treatment. Data are shown as the mean
of 30 independent determinations. Error is depicted as S.E. (***) Marks
significant difference to control ( P < 0.01).2. Material and methods
2.1. Cell culture and treatment
COS-1 cells (American Type Culture Collection, Rock-
ville, MD, USA) and 293 QBI cells were grown in DMEM
containing 10% fetal calf serum, 1% penicillin/streptomy-
cin. Cultivation was at 37 jC and 5% CO2. Treatment was
done on 8-chamber slides (Nunc). Cells were plated 24
h before treatment. Cells were treated with Ah 1–40
(Bachem, Heidelberg) at the concentrations indicated or
mock-treated (treated without peptide). Ah 1–40 was aged
for 5 days at 37 jC. Neurotoxicity was assayed before use as
described [11,12].
2.2. Vectors, transfection and translation
RAGE cDNA was cloned via PCR using published
sequences [1,13]. Expression vector pUT SV1 (pZEO
SV1) was obtained from Cayla, Toulouse, France. For
immunological detection, the stop codon of RAGE waschanged to include a HA tag (GYPYDVPDYA) fused to the
C-terminus. Cloning of PCR fragments were done using
EcoRI sites. Cells were transfected using FuGENE 6
(Roche) according to the protocols provided by the manu-
facturer. Selection of stable clones was done using 100 Ag/ml
Zeocin.
Vectors containing RAGE cDNAs were submitted to a
coupled in vitro transcription and translation reaction (TNT,
Promega). After separation of products on a 8% PAA, SDS
gel detection was done after blotting on a PVDF according
to the protocols provided by the manufacturer (Transcend,
Promega).
2.3. Immunostaining and cell death analysis
Cells were fixed for 2 min in EtOH and for 5 min in 3.7%
formaldehyde and immunostained with an anti-HA mAb
(Roche; diluted 1:50), detected with an anti-mouse Ab
coupled to Cy3 (Jackson Labs, 1:400). X-Gal staining of
lacZ transfected cells was done as previously described [11].
Cells were scored dependent on their morphology as dead or
alive as described by Ref. [14] using the following criteria:
cells alive depict a flat trapezoid morphology, whereas dead
cells are small and rounded up. Statistical analysis was
Fig. 3. Membrane localization of RAGE in transient transfectants. Immunostains (red) using anti-hemagglutinin antibodies were performed on RAGE HA-
transfected COS-1 cells (left panels) and 293 cells (right panels). Cell nuclei were stained with DAPI (blue). Cells transfected with empty expression vectors
(control) were depicted in lower panels. Arrows mark examples of membrane-localized immunoreactivity.
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test.3. Results
To determine the effect of RAGE on cell death, two
RAGE expression constructs were prepared; one contain-
ing the coding region of human RAGE and a second one
containing, in addition to RAGE, an influenza hemagglu-
tinin tag. In order to test if the proteins could be
expressed, both constructs were translated in vitro using
rabbit reticulocyte extracts. SDS page revealed that bothFig. 4. Localization of RAGE in stable transfectants. Examples of clones of COS-1
was detected in many COS-1 clones (see clones 7 and 3, left panels). 293 clone A6
depicted an intracellular localization (see arrow, middle right panel). Controls w
immunoreactivity in red; nuclei in blue).translation products showed the predicted molecular mass
(see Fig. 1).
To rule out a biological difference between the tagged
and the wild-type RAGE, transient transfectants were ana-
lyzed. Cell death was chosen as a read-out. Both wt RAGE
and tagged RAGE were transfected in COS-1 cells together
with a lacZ expression vector as a marker of transfected
cells. Blue cells were scored morphologically for cell death
[11]. Surprisingly, the transfection of both tagged and
untagged RAGE induced a considerable amount of cell
death, in comparison to lacZ transfectants (see Fig. 2). No
difference in the induction of cell death was observed
between tagged and untagged RAGE. Therefore, taggedand 293 transfectants are depicted. Surprisingly, no membrane localization
depicted membrane localization (see arrow, upper right panel) but clone E4
ere empty vector transfectants. Staining was done as for Fig. 3 (anti-HA
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advantage of easy immunological detection.
Stable tagged RAGE transfectants were analyzed, both in
HEK 293 and in COS-1 cells. Immunostaining with an
antibody directed against the HA tag of RAGE revealed a
robust protein expression (Fig. 3). Surprisingly, there were
two classes of clones, which differed in their localization of
RAGE. As expected, there are clones such as A6 (see Fig.
4), showing membrane staining (compare staining of trans-
fectants to control staining depicted in the lower panel). But
there are clones where RAGE seemed to be localized
intracellularly (see Fig. 4, clone E4). Both, the membrane
localized RAGE (clone A6) and the one with pronounced
intracellular localization (clone E4) are expressed at com-
parable levels, as visible in the immunofluorescence. Thus
there should be no differences in the potential RAGE
receptor availability.
Is there any biological function, which is different be-
tween those two clones with different cellular localization of
overexpressed RAGE? Both clones were tested for sensitiv-Fig. 5. Cell death analysis of stable RAGE transfectants treated with high doses
subjected to Ah treatment and cell death was determined after 24 h. (A) Phase c
increased sensitivity to Ah toxicity of clone A6 (membrane-localized RAGE). Dea
death reveals increased Ah sensitivity. Data are shown as mean (bar depicts 9
significant difference to mock-treated (without peptide) cells ( P < 0.05). Note that
RAGE).ity to Ah-mediated cell death (Fig. 5A). The human 293 cells
used here offer the advantage of being relatively flat on a
culture dish and thus dead cells could be easily identified
using morphological criteria. Visual inspection of transfected
293 cells was previously established also as a high through-
put screening for apoptosis by Grimm and Leder [14]. Here
we followed Grimm’s description and identified dead cells as
rounded non-flat cells, which is a very conservative estimate,
since many of the dead cells might be already in the
supernatant and will not be counted. A dose response curve
from 0.1 to 10 AMAhwas analyzed (Fig. 5B). At 10 AMAh
nearly all cells were dead, independently of the presumed
localization of RAGE. In contrast, a striking difference was
detected when using a concentration of 1 AM Ah. Cells with
membrane localized RAGE (clone A6) were clearly more
sensitive to Ah than cells with intracellular RAGE (clone
E4) or empty vector transfectants (mock). This hypersensi-
tivity to Ah was also detected at a concentration of 0.1 AM
Ah. Next, we asked if there might be a difference already
seen at even lower concentrations. When analyzing a con-of Ah. Two stable clones of 293 cells transfected with RAGE HA were
ontrast images of clones E4, A6 and empty vector transfectants. Note the
d cells are recognized as rounded up (see arrows). (B) Quantification of cell
5% confidence interval) of 10 independent determinations. A star marks
1 AM induces significant cell death only in clone A6 (membrane-localized
Fig. 6. Cell death analysis of stable RAGE transfectants treated with low
doses of Ah. Data are shown as mean (bar depicts 95% confidence interval)
of 10 independent determinations. A star marks significant difference to
mock-treated cells (untr.) ( P < 0.05). Note that 0.01 AM already induces
significant cell death, but only in clone A6 (membrane-localized RAGE).
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hypersensitivity of RAGE transfectants (Fig. 6, clone A6)
could already be detected at a concentration of 0.01 AM Ah.
Taken together, surface expression of RAGE induces a vastly
increased sensitivity to normally subtoxic Ah amounts.4. Discussion
This study demonstrates that RAGE overexpression
sensitizes transfected cells to Ah induced cell death in
two model cell lines (COS-1 and HEK 293). Cell death
was already induced in transient transfectants. This might
explain why the RAGE expressing stable clones could be
isolated at a lower frequency in comparison to the lines
transfected with the vector without RAGE cDNA. Not only
overexpression, but also localization of RAGE is important
for cell death induction. Cells with a stable intracellular
localization of RAGE could be isolated from both cell lines.
As hypothesized from the immunolocalization of tagged
RAGE, these cells were resistant to Ah-induced cell death.
We conclude that Ah-induced cell death of RAGE trans-
fectants is not based on any unspecific sensitivity of cells
overexpressing a protein, but is based on RAGE as cell
surface membrane receptor of Ah. No difference in the cell
death inducing capability of tagged and untagged RAGE
was detected. This might argue for an intracellular domain
of RAGE, which is signaling independently of the HA-tag.
In transient transfections, we observed a high amount of cell
death in comparison to cells transfected with the vector
backbone of RAGE expression constructs. This might bedue to low amounts of Ah already present in the culture
medium as a consequence of the ubiquitous expression of
Ah precursor protein. There are several intracellular reac-
tions described, which follow the activation of RAGE.
Many of the described physiological reactions of RAGE
activation evoke proliferation or cell differentiation. Prom-
inent example of RAGE-mediated proliferation is tumor
growth [7]. Binding of protein ligand amphoterin to RAGE
on cortex neurons induced increased formation of neurites
[3,15]. RAGE ligation in embryonic stem cells promoted
neuronal differentiation [16]. In neuroblastoma cells differ-
entiated with retinoic acid, RAGE seems to be more
important for survival [17]. Soluble AGEs could similarly
to Ah induce migration of monocytes, whereas surface fixed
ligands of RAGE could fix the cells to the ligation of the
ligand [4]. These different, partly counteracting reactions
exemplify, that RAGE activation might only be the first step
of a signaling cascade with great divergence. Some further
details of the intracellular processes following RAGE acti-
vation are already highlighted. For both RAGE-dependent
neurite outgrowth and RAGE-dependent NF-nB activation,
the cytoplasmic RAGE domain is necessary. Divergence
develops through different intracellular interactions with the
intracellular RAGE domain. For neurite outgrowth activa-
tion of the GTPases Rac and Cdc42 seems to be essential.
But for NF-nB activation, the GTPase Ras might be neces-
sary [18]. Which components are involved in RAGE-medi-
ated cell death is currently under investigation. What directs
the membrane or intracellular localization of RAGE is
currently unknown. This might very well require additional
proteins or receptors, which are only available in limiting
amounts. Future studies will address the potential of further
RAGE interacting proteins.References
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